The first participant has been dosed in a Phase 2 clinical trial testing the experimental therapy namilumab in people with…
Articles by Marisa Wexler, MS
Among sarcoidosis patients referred for lung transplant, the risk of death while on the waitlist is higher for…
A new type of biochemical analysis called ACE phenotyping may help diagnose sarcoidosis involvement outside the lungs, a study…
Efzofitimod, an experimental treatment for pulmonary sarcoidosis that’s set to begin Phase 3 clinical testing later this year,…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
Having an ultrasound of the neck may be useful for diagnosing certain cases of sarcoidosis — and for ruling…
INOpulse, a device that administers inhaled nitric oxide, significantly improved blood flow parameters in a small proof-of-concept clinical trial…
Most people living with sarcoidosis are overall satisfied with their health insurance provider and are not considering changing their…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Xentria is seeking regulatory approval to begin clinical trials to test XTMAB-16, its investigational TNF-alpha inhibitor for the treatment…